Does GIANVI Cause Thrombophlebitis superficial? 9 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Thrombophlebitis superficial have been filed in association with GIANVI. This represents 4.3% of all adverse event reports for GIANVI.
9
Reports of Thrombophlebitis superficial with GIANVI
4.3%
of all GIANVI reports
0
Deaths
4
Hospitalizations
How Dangerous Is Thrombophlebitis superficial From GIANVI?
Of the 9 reports, 4 (44.4%) required hospitalization.
Is Thrombophlebitis superficial Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GIANVI. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does GIANVI Cause?
Injury (135)
Pain (113)
Deep vein thrombosis (89)
Emotional distress (89)
Pulmonary embolism (84)
Anxiety (42)
General physical health deterioration (33)
Anhedonia (30)
Cholecystitis chronic (21)
Thrombosis (20)
What Other Drugs Cause Thrombophlebitis superficial?
DROSPIRENONE\ETHINYL ESTRADIOL (160)
LENALIDOMIDE (121)
ETHINYL ESTRADIOL\ETONOGESTREL (93)
RIVAROXABAN (82)
YAZ (78)
YASMIN (65)
TESTOSTERONE (62)
HUMAN IMMUNOGLOBULIN G (43)
ADALIMUMAB (40)
CAPECITABINE (29)
Which GIANVI Alternatives Have Lower Thrombophlebitis superficial Risk?
GIANVI vs GLASDEGIB
GIANVI vs GLATIRAMER
GIANVI vs GLIPIZIDE
GIANVI vs GLUCOPHAGE
GIANVI vs GLUTAMINE